IFN-γ has thus become recognized as a major contributor to the immunogenicity of malignancy. The CD4+ T helper cells and CD8+ cytotoxic T cells are the effector T cells that release IFN-γ.

This study aimed to investigate the dynamics of peripheral blood T lymphocyte subsets during peginterferon alpha (peg-IFN-α) therapy and their association with hepatitis B surface antigen (HBsAg ...